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SUMMARY
Plasma membrane (PM) free cholesterol (FC) is
emerging as an important modulator of signal trans-
duction. Here, we show that hepatocyte-specific
knockout (HSKO) of the cellular FC exporter, ATP-
binding cassette transporter A1 (ABCA1), leads to
decreased PM FC content and defective trafficking
of lysosomal FC to the PM. Compared with controls,
chow-fed HSKO mice had reduced hepatic (1) insu-
lin-stimulated Akt phosphorylation, (2) activation of
the lipogenic transcription factor Sterol Regulatory
Element Binding Protein (SREBP)-1c, and (3) lipo-
genic gene expression. Consequently, Western-
type diet-fed HSKO mice were protected from stea-
tosis. Surprisingly, HSKO mice had intact glucose
metabolism; they showed normal gluconeogenic
gene suppression in response to re-feeding and
normal glucose and insulin tolerance. We conclude
that: (1) ABCA1 maintains optimal hepatocyte PM
FC, through intracellular FC trafficking, for efficient
insulin signaling; and (2) hepatocyte ABCA1 deletion
produces a form of selective insulin resistance so
that lipogenesis is suppressed but glucose meta-
bolism remains normal.
INTRODUCTION
On binding to its receptor, insulin stimulates signaling events
that, ultimately, profoundly change metabolism (Biddinger and
Kahn, 2006). One such change is the stimulation of hepatic lipo-
genesis (Horton et al., 1998). Defective insulin signaling occurs in
obesity, diabetes, and metabolic syndrome (Leavens and Birn-
baum, 2011; Saltiel and Kahn, 2001). Changes in plasma mem-
brane (PM) free cholesterol (FC) content and phospholipid
species (i.e., fatty acyl and head group) modulate the signaling
of multiple receptors (Simons and Toomre, 2000), suggesting
that PM FC content could also regulate insulin signaling. In sup-
port of this notion, excess PM FC in Niemann-Pick C1 knockout
hepatocytes, or chemical depletion of PM FC (i.e., too little PM
FC) in wild-type hepatocytes, blunted insulin receptor autophos-
phorylation, hinting that optimal PM FC is necessary for efficient
insulin receptor activation (Vainio et al., 2002, 2005).
ATP binding cassette transporter A1 (ABCA1) effluxes FC and
phospholipid (PL) across the PM to combine with apolipopro-
teins (i.e., apoA–I), forming nascent high-density lipoproteins
(HDLs) (Oram and Vaughan, 2006). While a role for ABCA1 in
bulk cellular FC export is well recognized (Oram and Vaughan,
2006), recent studies suggest that ABCA1 modifies PM lipid
composition, which results in altered signaling via PM receptors.
For example, myeloid-specific deletion of Abca1 results in mac-
rophages with increased PM FC and lipid raft content (Zhu et al.,
2008, 2010). These macrophages are hyper-responsive to path-
ogen-associated molecular pattern molecules due to increased
localization of Toll-like receptors and adaptor proteins in lipid
rafts (Ito et al., 2015; Zhu et al., 2012), which increases macro-
phage secretion of proinflammatory cytokines (Zhu et al.,
2008), chemotaxis in vitro and in vivo, and clearance of live bac-
teria from circulation (Zhu et al., 2012). Increased PM FC in he-
matopoietic stem and multipotential progenitor cells augments
signaling through the interleukin-3 (IL-3) receptor and cell prolif-
eration (Murphy et al., 2011; Yvan-Charvet et al., 2010).
Recently, ABCA1 was implicated in modifying membrane lipid
composition and multiple signaling activities in response to cell
crowding (Frechin et al., 2015).
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Figure 1. Hepatic Insulin and Glucagon Signaling and Transcriptome Profile
(A) Mice (n = 4 per genotype) were fasted and then fed chow for 2 hr. Blood samples were obtained and isolated plasma used to measure total cholesterol (TC)
concentration.
(B) Western blot of liver Akt activation.
(C) Western blot of hepatocyte Akt activation.
(D and E) Glucagon signaling in primary hepatocytes. (D) Cyclic AMP (cAMP) levels measured with ELISA. (E) PKA phosphorylation substrates (pPKA substrates)
were determined by western blotting.
(F and G) Chow-fed mice were fasted for 4 hr, and livers were harvested for RNA-seq (n = 3 per genotype). (F) Heatmap and clustering of 3,000 most variably
expressed genes in the normalized RNA-seq dataset. (G) PCA analysis.
(legend continued on next page)
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Several lines of indirect evidence suggest that ABCA1 may be
involved in insulin signaling. Chow-fed Abca1 global KO mice
develop hyperglycemia by 4 months of age, and pancreatic
b cell-specific deletion of Abca1 results in islet cell FC accumu-
lation and defective insulin release, leading to hyperglycemia
(Brunham et al., 2007). Chow-fed hepatocyte-specific Abca1
knockout (HSKO) mice show phenotypic lipid changes similar
to those in type 2 diabetes and metabolic syndrome (Adiels
et al., 2005), including elevated non-fasting plasma triglyceride
(TG) levels from hepatic overproduction of large TG-enriched
VLDL1 (very low-density lipoprotein 1) particles and low plasma
HDL concentrations (Chung et al., 2010). Chow-fed HSKO mice
also have diminished phosphoinositide 3-kinase (PI3K) and Akt
activation with fasting and refeeding or acute insulin injection
(Chung et al., 2010). Chow-fed female HSKOmice have impaired
glucose tolerance but unchanged insulin sensitivity (de Haan
et al., 2014a). Mounting evidence suggests that ABCA1 SNPs
are associated with type 2 diabetes and metabolic syndrome
in humans (Daimon et al., 2005; Porchay et al., 2006; Villarreal-
Molina et al., 2007, 2008). Nonetheless, a direct role of ABCA1
in insulin receptor signaling has not been reported.
Here, we sought to determine whether hepatocyte ABCA1
expression affects PM lipid composition, insulin signaling, and
lipogenesis. Although liver FC and CE content are similar in
chow-fed HSKO and control mice (Chung et al., 2010), we hy-
pothesized that hepatocyte PM cholesterol is elevated in
HSKO mice, resulting in blunted insulin signaling in livers of
chow-fed HSKO mice versus control mice. This hypothesis
was based on reports that myeloid-specific deletion of ABCA1
results in macrophages with increased PM FC and lipid raft con-
tent (Zhu et al., 2008, 2010), and optimal PM FC content is
necessary for hepatocyte insulin signaling (Vainio et al., 2002,
2005).
RESULTS
Hepatocyte-Specific Abca1 Deletion Modifies Hepatic
Insulin and Glucagon Signaling in Chow-Fed Mice
Chow-fed HSKO mice had total plasma cholesterol concentra-
tions 72%–78% lower (p < 0.0001) than in Abca1floxed/floxed
(fl/fl) control mice (Figure 1A), as previously reported (Chung
et al., 2010; Timmins et al., 2005). Although body weight and
food intake decreased and blood glucose and plasma insulin
increased in chow-fed HSKO mice, the systemic metabolic
phenotype (Figures S1A–S1Q) was not statistically different
from that of fl/fl mice.
We reported earlier that chow-fed HSKO mice had reduced
hepatic phosphorylation of Akt serine residue 473 (S473) and
PI3K p85 compared to controls, suggesting hepatic insulin resis-
tance in HSKO mice (Chung et al., 2010). Complete Akt activa-
tion requires phosphorylation at S473 and threonine residue
308 (T308) (Cheng and White, 2012; Wu and Williams, 2012).
Here, we observed that both phosphorylated sites were
decreased in the liver (Figure 1B) and hepatocytes (Figure 1C)
of chow-fed HSKO versus control mice.
We also investigatedwhether hepatocyte ABCA1deletion also
affected glucagon signaling, which activates adenylate cyclase,
resulting in increased cyclic AMP (cAMP) concentration and
cAMP-induced protein kinase A (PKA) activity (Campbell and
Drucker, 2015). Incubation of hepatocytes from chow-fed
HSKO mice with glucagon led to a doubling of cAMP levels (Fig-
ure 1D; p < 0.001) and substrates of PKA phosphorylation,
compared to hepatocytes from fl/fl control mice (Figure 1E).
Hepatocyte-Specific Abca1 Deletion Impairs Hepatic
De Novo Lipogenesis
We applied an unbiased RNA-sequencing (RNA-seq) approach
to identify differential gene signatures in livers of chow-fed
HSKO versus fl/fl control mice. We obtained an average of
100million paired-end reads per sample,85%of which map-
ped uniquely to themouse genome. Clustering analysis using the
3,000 most variably expressed genes correctly distinguished the
fl/fl and HSKO mice (Figure 1F). This clustering was confirmed
(1) by analyzing the 3,000 most highly expressed genes (Fig-
ure S2A) and the 10,000 most variable or most highly expressed
genes (data not shown) and (2) by principal-component analysis
(PCA) (Figure 1G). The mRNA expression levels of 906 genes
were significantly altered in livers of HSKO versus fl/fl control
mice, including 226 downregulated (<2 fold) and 680 upregu-
lated (>2-fold) genes (both unadjusted p = 0.05; Tables S1 and
S2). As expected, Abca1 mRNA was among the most signifi-
cantly downregulated (90% loss, unadjusted p = 3.2E05;
Table S1). Using the Reactome 2016 database, the 226 downre-
gulated genes were most significantly overrepresented in path-
ways related to lipogenesis, including fatty acyl-coenzyme A
(CoA) synthesis (p = 0.0006) and TG biosynthesis (p = 0.0009)
(Figure 1H; Table S3). Moreover, using the BioCarta 2016
resource, sterol regulatory element binding protein (SREBP)
control of lipid synthesis is one of only two significantly enriched
pathways (p = 0.01) among downregulated genes (Table S3). We
verified these findings by real-time qRT-PCR for genes that
encode key enzymes in lipogenesis (Figure S2B).
Primary hepatocytes were isolated from chow-fed mice, and
rates of TG, FC, PL, and cholesteryl ester (CE) synthesis were
determined by measuring the incorporation of [14C]-acetic acid
(i.e., de novo lipogenesis) and [3H]-oleic acid (TG formation by
fatty acid [FA] esterification) into hepatocyte lipids. TG (Fig-
ure 2A), FC (Figure 2B), PL (Figure 2C), and CE (Figure 2D) syn-
thesis from [14C]-acetic acid was significantly decreased in
hepatocytes from HSKO versus fl/fl control mice, supporting
the RNA-seq results. TG (Figure 2E), but not PL (Figure 2F) and
CE (Figure 2G), formation by [3H]-oleic acid esterification was
significantly reduced in HSKO hepatocytes, suggesting that
the primary effect of hepatocyte ABCA1 deletion was on
de novo lipogenesis and somewhat on FA uptake and esterifica-
tion into TG.
(H) Pathway analysis of RNA-seq dataset using the Reactome 2016 database.
In (A)–(E), results are representative of two to three separate experiments.
*p < 0.05; **p < 0.01; ***p < 0.001; and ***p < 0.0001. All results are mean ± SEM.
See also Figures S1 and S2.
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Since insulin signaling was blunted and lipogenesis was
decreased in HSKO hepatocytes, compared to fl/fl hepato-
cytes, we examined expression and proteolytic processing of
SREBP1c, the master regulator of de novo lipogenesis (Gold-
stein and Brown, 2015). Mice were subjected to a 24-hr fast fol-
lowed by 8-hr refeeding of a high-carbohydrate chow diet, which
results in robust expression and proteolytic processing of
SREBP1c as insulin levels rise during the refeeding period
(Engelking et al., 2004; Haas et al., 2012; Horton et al., 1998).
After a 24-hr fast, minimal full-length or processed SREBP1c
was observed (Figure 2H) due to low insulin levels. However, af-
ter 8 hr of refeeding when insulin is high, full-length SREBP1c
and nuclear-processed SREBP1c were markedly reduced in
HSKO versus fl/fl liver (Figure 2H). As anticipated (Yabe et al.,
2003), after 8 hr of refeeding, Srebp1c (25-fold, p < 0.0001), FA
synthase (Fasn; 8-fold, p < 0.01), acetyl-CoA carboxylase 1
(Acc1; 2-fold, p < 0.01), Srebp2 (2-fold, p < 0.05), and Insig1
(11-fold, p < 0.01) hepatic mRNA increased; and Insig2a and
Lipin1a decreased (Figure 2I) in both genotypes. However,
HSKO mouse liver had significantly lower mRNA for Srebp1c
after the 8-hr refeeding period and a trend toward less Fasn
and Insig1 mRNA versus refed fl/fl livers (Figure 2I).
We also examined signaling proximal and distal to the mech-
anistic target of rapamycin C1 (mTORC1), a bifurcation point
between insulin-stimulated lipogenesis and gluconeogenesis
(Li et al., 2010), using insulin-stimulated primary hepatocytes
isolated from chow-fed mice. We observed significantly
decreased phosphorylation of tuberous sclerosis complex 2
(TSC2), ribosomal protein S6 kinase 1 (S6K1), eukaryotic initia-
tion factor 4E-binding protein 1 (4E-BP1), and glycogen synthase
3b (GSK3b), but not proline-rich Akt substrate of 40 kDa
(PRAS40), in hepatocytes from chow-fed HSKO versus fl/fl
mice (Figures 2J and S2C), supporting decreased mTORC acti-
vation and de novo lipogenesis in HSKO hepatocytes.
Hepatocyte-Specific Abca1 Deletion Does Not Impair
Hepatic Glucose Metabolism
As anticipated (Yabe et al., 2003), 8 hr of refeeding after a
24-hr fast decreased mRNA abundance for the gluconeogenic
genes phosphoenolpyruvate carboxykinase (Pepck; p < 0.01),
glucose-6-phosphatase (G6pc; p = 0.2), insulin receptor sub-
strate 2 (Irs2; p = 0.1), and insulin-like growth-factor-binding
protein 1 (Igfbp1; p < 0.01), and it increased expression of the
glycolysis gene glucokinase (Gck; p = 0.001) in livers of fl/fl con-
trol mice (Figure 2K). HSKOmouse liver had higher mRNA abun-
dance for G6pc (p < 0.05) and Igfbp1 (p < 0.0001) after the 24-hr
fast and lower Pepck,G6pc, Irs2, and Igfbp1mRNA versus refed
fl/fl livers (Figure 2K). In agreement with results in Figure 2K, we
observed increased nuclear FoxO1; on refeeding, nuclear FoxO1
appeared slightly lower in HSKO livers versus fl/fl livers (Fig-
ure 2H). Overall, these results show that FoxO1 signaling is unim-
paired in fasted-refed HSKO versus fl/fl mice.
Hepatocyte-Specific Abca1Deletion Stimulates Hepatic
FA Oxidation
Since our RNA-seq results suggested that FA oxidation path-
ways were downregulated in HSKO liver (Table S3), we
measured rates of FA uptake and oxidation of [14C]-palmitic
acid into [14C]-CO2 and [
14C]-acid-soluble metabolites (ASMs).
FA oxidation was increased in hepatocytes from chow-fed
HSKO versus fl/fl mice (Figures S2D and S2E), whereas FA
uptake was similar (Figure S2F).
Hepatocyte-Specific Abca1 Deletion Improves
Metabolic Phenotype of WTD-Fed Mice
We challenged chow-fed HSKO mice with a Western-type diet
(WTD), which decreased their weight versus fl/flmice (Figure 3A).
WTD-fed HSKO mice had significantly increased oxygen con-
sumption (Figure 3B) and energy expenditure (Figure 3C),
without changes in food intake, physical activity, or respiratory
exchange ratio (Figures S3A–S3C). Similar to our previous re-
ports (Chung et al., 2010; Timmins et al., 2005), HSKO mice
had reduced plasma LDL (low-density lipoprotein) cholesterol
and HDL cholesterol concentrations, compared to fl/fl mice on
both chow andWTD (Figure S3D). Other measures of a systemic
metabolic phenotype between WTD-fed HSKO and fl/fl mice
were similar (Figures S3E–S3L). However, liver TG (Figures 3D
and 3E) and FC (Figure 3F) levels were decreased 70%
(p < 0.0001) and 20% (p < 0.01), respectively, in WTD-fed
HSKO versus fl/fl control mice. TG (Figure 3G) and FC (Figure 3H)
levels were also decreased 70% (p < 0.0001) and 30% (p < 0.01),
respectively, in hepatocytes from WTD-fed HSKO versus fl/fl
control mice.
To determine the mechanism for reduced hepatosteatosis in
WTD-fed HSKO mice, we examined several pathways that influ-
ence hepatic TG content. Incorporation of [14C]-acetic acid into
TG (Figure 4A) and PL (Figure 4B) was significantly decreased in
primary hepatocytes isolated from WTD-fed HSKO versus fl/fl
control mice, demonstrating decreased hepatic de novo lipo-
genesis. Newly synthesized FC (Figure 4C) from [14C]-acetic
acid was similar between genotypes, likely due to feedback inhi-
bition by cholesterol in theWTD. [3H]-oleic acid esterification into
hepatocyte TG (Figure 4D) and PL (Figure 4E) was also reduced
in hepatocytes fromWTD-fed HSKO mice, similar to results with
Figure 2. Lipid Metabolism in Hepatocytes from Chow-Fed Mice
(A–G) Primary hepatocytes were incubated with the indicated radiolabels and newly synthesized TG (A and E), FC (B), PL (C and F), and CE (D and G) measured
(n = 3 per time point).
(H and I) Mice (n = 3 per genotype) underwent fasting and refeeding; nuclear and total liver protein (H) and total RNA (I) from mouse livers were subjected to
western blotting and real-time PCR quantification, respectively.
(J) Primary hepatocytes were treated with saline () or insulin (+) for 2 min to examine pTSC2, TSC2, pPRAS40, and PRAS40 or 5 min to examine pS6K1, S6K1,
pGSK3b, Gsk3b, p4E-BP1, and 4E-BP1 protein expression.
(K) Real-time PCR quantification of glucose metabolism genes. Same experimental conditions and animals as in (I).
Results are representative of two to three separate experiments. *p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001; for multiple comparisons, different
lowercase letters denote significant differences, p < 0.05. All results are mean ± SEM.
See also Figure S2.
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[14C]-acetic acid. WTD-fed HSKOmice, versus fl/fl control mice,
also had decreased hepatocyte [14C]-palmitic acid uptake (Fig-
ure 4F), decreased liver CD36/FA translocase mRNA levels (Fig-
ure 4G; 50%, p < 0.001), and reduced liver PM and cytosolic
CD36/FA translocase protein expression (Figure 4H); however,
hepatocyte FA oxidation was similar (Figures S4A and S4B),
as was hepatic gene expression of peroxisome-proliferator-
activated receptor a (Ppara), carnitine palmitoyltransferase 1
(Cpt1), and Acc2 (Figure S4C). Lastly, in vivo secretion of newly
synthesized VLDL-TG from [3H]-oleic acid (Figures S4D and
S4E) was similar for WTD-fed wild-type (WT) and HSKO mice.
Thus, attenuated diet-induced hepatosteatosis in HSKO mice
was most likely due to decreased hepatic de novo lipogenesis
and FA uptake.
Impaired Hepatic Insulin Signaling in HSKO Liver Is
Associated with Decreased PM FC and Increased
Hepatic Lyso-PL Levels
Portal vein insulin injection in WTD-fed HSKO mice resulted in
decreased hepatic insulin-stimulated Akt S473 and T308 phos-
phorylation versus controls (Figure 5A). However, white adipose
tissue (Figure S5A) and skeletal muscle (Figure S5B) insulin
signaling was similar for both genotypes, suggesting that insulin
signaling was selectively impaired in hepatocytes lacking
ABCA1 expression. We also isolated liver PM from mice with a
portal vein insulin injection. WTD-fed HSKO liver had decreased
PM insulin receptor phosphorylation, but there was no change in
insulin receptor b protein expression versus that in fl/fl control
mice, suggesting decreased activation of hepatic insulin recep-
tor in WTD-fed HSKO mice (Figure 5B).
We hypothesized that hepatocyte-specific ABCA1 deletion
increased PM FC content, leading to impaired insulin signaling.
Primary hepatocytes from chow- or WTD-fed mice were used
to isolate PM fractions, which were then lipid extracted to mea-
sure FC. The PM fraction (enriched in Na+/K+ ATPase) isolated
from chow-fed mouse hepatocytes was relatively free of cal-
nexin and perilipin 2 (Figure 5C). We also examined the abun-
dance of PM flotillin 1, a protein associated with caveolar
lipid rafts (Bickel, 2002; Bickel et al., 1997). Hepatocyte PM flo-
tillin 1 (Figure 5C) and FC (Figure 5D; 60%, p < 0.05) content
were significantly decreased in chow-fed HSKO versus control
mice. As with our chemical measurement of PM FC, filipin stain-
ing was decreased in the PM region of chow HSKO versus fl/fl
hepatocytes (Figure S5C).
Figure 3. Metabolic Phenotype of WTD-Fed Mice
Male mice were fed a WTD for 16–24 weeks.
(A) Body weight (BW); n = 9.
(B) Oxygen consumption rates (VO2) in milliliters per kilogram per hour (mL/kg/hr).
(C) Energy expenditure (EE) in kilocalories per kilogram per hour (kcal/kg/hr).
(D) Oil red O staining of representative liver sections from 16-week WTD-fed mice.
(E–H) Liver TG (E) and FC (F) and hepatocyte TG (G) and FC (H) from WTD-fed mice. Data are representative of two to three separate experiments.
*p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001. All results are mean ± SEM.
See also Figure S3.
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HSKO hepatocyte PM flotillin 1 and FC content were nor-
malized after the addition of 10% fetal bovine serum (FBS;
300 mg cholesterol per milliliter) to control hepatocyte levels
(data not shown), demonstrating that acute repletion of HSKO
hepatocyte PM cholesterol was possible with FBS-containing
lipoproteins.
We performed a lipidomic analysis of PL species in chow-fed
fl/fl andHSKOmouse livers.Hepatic content of phosphatidylcho-
line (PC), phosphatidylethanolamine (PE), phosphatidylinositol
(PI), phosphatidylserine (PS), and phosphatidic acid (PA) were
unaffected by ABCA1 expression (Figure S5D). However, lyso-
PC, lyso-PE, and lysophatidylglycerol (lyso-PG) were signifi-
cantly increased (1.9-, 1.5-, and 2.8-fold, respectively, p < 0.01)
in HSKO liver versus fl/fl liver (Figure 5E). HSKO liver lyso-PC
and lyso-PE species also contained less saturated and monoun-
saturated fatty acyl species versus polyunsaturated species (Fig-
ure 5F, Sat+Mono/Poly ratio), compared to fl/fl liver (p < 0.05),
suggesting a selective remodeling of hepatic lyso-PL without
ABCA1.
We also measured hepatocyte PM cholesterol and flotillin 1
content from WTD-fed mice. Compared to chow-fed mice
(Figure 5C), PM fractions from WTD-fed mice were likely
contaminated with lipid droplets based on perilipin 2 content
(Figure 5G). Regardless, PM flotillin 1 (Figure 5G) and FC
content (Figure 5H) were decreased by 30% (p < 0.001) in pri-
mary hepatocytes isolated from WTD-fed HSKO mice versus
controls.
To directly test effects of acute cholesterol depletion and
repletion on insulin signaling, we treated hepatocytes from
WTD-fed mice with methyl-b-cyclodextrin (MbCD) or choles-
terol-loadedMbCD and then stimulated them acutely with insulin
and measured Akt phosphorylation. MbCD-treated hepatocytes
had no detectable Akt phosphorylation for both genotypes (Fig-
ure 5I) and reduced cellular FC content (Figure 5J). Incubation of
MbCD-treated hepatocytes with cholesterol-loaded MbCD
increased cellular FC and restored insulin-stimulated Akt phos-
phorylation, both above basal levels for both genotypes (Figures
5I and 5J), demonstrating that acute FC depletion and repletion
Figure 4. Lipid Metabolism in Primary Hepatocytes from WTD-Fed Mice
(A–E) Primary hepatocytes fromWTD-fedmice (n = 2 per genotype) were incubated with the indicated radiolabels and newly synthesized 14C-triglyceride (TG) (A),
14C-phospholipid (PL) (B), 14C-free cholesterol (FC) (C), 3H-TG (D), and 3H-PL (E) were measured (n = 3 per time point).
(F) FA uptake by primary hepatocytes was measured as in Figure 2 (n = 3 per time point); two-way ANOVA with Bonferroni’s multiple comparison test.
(G) Cd36 expression by real-time PCR.
(H) Hepatic CD36, Na+/K+ ATPase, and GAPDH protein expression.
Results are representative of two to three separate experiments. *p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001. All results are mean ± SEM. DPM,
disintegrations per minute.
See also Figure S4.
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Figure 5. Primary Hepatocyte PM FC Content Modulates Insulin Signaling
Mice consuming a WTD for 16–24 weeks received a portal vein saline (n = 2 per genotype) or an insulin (0.5 U/kg of body weight; n = 3 per genotype) injection;
5 min later, livers were harvested.
(A) Liver western blots. p, phosphorylated.
(B) Western blots of hepatic membrane-associated and cytosolic (Cyto.) proteins. LIRKO, liver-specific insulin receptor knockout.
(C and D) Primary hepatocytes from chow-fed mice (n = 2 per genotype) were used to purify PM fractions (n = 3 per treatment) for western blot (C) and FC
measures (D).
(E and F) Liver lipids were extracted from chow-fed mice (n = 4 per genotype) to measure lysophospholipid content (E) and fatty acyl species (F), which are shown
as the ratio of saturated (Sat) + monosaturated (Mono) divided by polyunsaturated (Poly) fatty acyl chains.
(G and H) Primary hepatocytes from WTD-fed mice (n = 2 per genotype) were used to purify PM (n = 6 per treatment) for western blotting (G) and FC
quantification (H).
(I) Primary hepatocytes from WTD-fed mice (n = 2 per genotype) were FC depleted (+MbCD) and repleted (+cholesterol) before insulin stimulation (n = 3 per
treatment) and western blotting.
(J) Cells from (I) were lipid extracted and FC measured. Chol., cholesterol.
Results are representative of two to three separate experiments. *p < 0.05; **p < 0.01; ***p < 0.001. All results are mean ± SEM.
See also Figure S5.
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resulted in decreased and increased insulin-stimulated sig-
naling, respectively.
Hepatic Abca1 Deletion Impairs Antegrade FC
Trafficking from Lysosomes to the PM
Since we observed a significant decrease in HSKO hepatocyte
PM FC content (Figure 5D)—but not total cellular FC level (Fig-
ure S1I)—compared to fl/fl controls, we hypothesized that intra-
cellular cholesterol trafficking is defective in ABCA1-deficient
hepatocytes. Because LDL trafficking from endosomes to lyso-
somes is blocked at 18C (Jones, 1997; Sugii et al., 2003), we
incubated primary hepatocytes isolated from chow-fed mice
with [3H]-cholesteryl-oleate-containing LDL at 18C for 5 hr to
pulse-label the endosomal compartment. Radiolabel was
chased for 90 min at 37C to allow LDL trafficking to the lyso-
some and hydrolysis of LDL [3H]-cholesteryl oleate to [3H]-FC
and oleic acid. Cell-associated (bound + internalized) [3H]-total
(CE + FC) cholesterol trended higher (p = 0.06) in chow-fed
HSKO versus fl/fl hepatocytes (Figure 6A) after the pulse period,
possibly due to increased hepatic LDL receptor protein expres-
sion in HSKO liver (Chung et al., 2010). During the pulse period,
some hydrolysis of LDL [3H]-cholesteryl oleate occurred, de-
tected as higher cell-associated FC radiolabel compared to
the LDL tracer (5% FC; 95% CE) (Figure 6B); increased FC
radiolabel was significantly higher in HSKO (28% FC) versus
fl/fl (17% FC) hepatocytes (Figure 6B), likely reflecting the higher
total cell-associated radiolabel in HSKOhepatocytes (Figure 6A).
To monitor the arrival of [3H]-FC at the PM during the chase
period, hepatocytes were incubated with MbCD for 5 min at
37C, followed by lipid extraction of cells and media and isola-
tion of [3H]-FC by thin-layer chromatography (Sugii et al.,
2003). Despite more [3H]-FC radiolabel in HSKO cells (Fig-
ure 6B), MbCD-extractable PM [3H]-FC was lower for HSKO
hepatocytes at zero time (42%, p < 0.001) and all three chase
times (32%, p < 0.01; 31%, p < 0.01; and 20%, p < 0.05, respec-
tively) relative to fl/fl hepatocytes (Figure 6C), suggesting
impaired antegrade trafficking of lysosomal FC to the PM in
HSKO hepatocytes.
DISCUSSION
Prior studies suggest that ABCA1may be important in regulating
systemic glucose metabolism and hepatic insulin signaling
(Brunham et al., 2007; Chung et al., 2010; de Haan et al.,
2014b), but mechanisms were unclear. A summary of our find-
ings appears in Figure 7A. Compared to control (fl/fl) mice,
HSKO mice had decreased hepatic insulin receptor signaling
due to decreased PM FC content that likely resulted from defec-
tive antegrade lysosomal FC trafficking to the PM and decreased
cholesterol biosynthesis. Decreased PM FC content and
impaired PM signaling led to decreased mTORC activation; an
50% reduction in SREBP1c mRNA abundance; decreased un-
processed, full-length SREBP1c; and low levels of processed
nuclear SREBP1c, a critical transcriptional activator of de novo
lipogenesis. Feeding a WTD to HSKO mice, compared to fl/fl
controls, markedly decreased hepatic TG content, associated
with decreased de novo lipogenesis and FA uptake and a mild
metabolic phenotype (reduced body weight and increased en-
ergy expenditure). Nonetheless, hepatic and systemic glucose
metabolism remained intact. Our results support the concept
that hepatocyte ABCA1 is critical for maintaining optimal PM
FC content for efficient membrane (particularly insulin) signaling.
Without hepatocyte ABCA1, a unique form of insulin resistance is
unmasked, where de novo lipogenesis is suppressed, but gluco-
neogenesis remains responsive (Figure 7B).
A striking result of our study was decreased hepatic insulin
signaling and de novo lipogenesis in HSKOmice. Li et al. showed
that insulin signaling bifurcates at the level of mTORC activation,
with one pathway stimulating de novo lipogenesis and one inhib-
iting gluconeogenesis (Li et al., 2010). Akt-dependent lipogen-
esis requires mTORC activation (Porstmann et al., 2008). Our
results show that components of the insulin signaling pathway
proximal (PI3K [Chung et al., 2010] and Akt) and distal (S6K
and 4E-BP1) to mTORC are attenuated in HSKO versus fl/fl liver.
Decreased de novo lipogenesis in HSKO liver is supported by
reduced SREBP1c mRNA, protein expression, and protein
processing and by biochemical measurements. Decreased
SREBP1c processing and lipogenesis in HSKO livers were
most likely due to impaired insulin receptor activation resulting
from reduced PM FC, since SREBP1c mRNA and full-length, un-
processed protein decreased in a manner proportional to that of
processed nuclear SREBP1c. However, increased endoplasmic
reticulum (ER) FC content, which would result in increased ER
retention of SCAP-SREBP1c by INSIG (Engelking et al., 2004;
Yabe et al., 2002), may be partially responsible for decreased
de novo lipogenesis in HSKO liver.
Figure 6. Defective Intracellular FC Traf-
ficking in ABCA1-Deficient Hepatocytes
Hepatocytes (n = 3 per treatment) were isolated
from chow-fed, male mice and incubated with
[3H]-cholesteryl-oleate-radiolabeled low-density
lipoprotein (LDL) tracer for 5 hr at 18C.
(A and B) After the 5-hr pulse, (A) cell-associated
[3H]-TC and (B) percent FC were quantified. DPM,
disintegrations per minute.
(C) After incubation with LDL tracer, cells were
chased for 0, 15, 30, and 90 min at 37C and then
treated with 3 mM MbCD for 5 min at 37C to
extract PM [3H]-FC.
Results are representative of two separate exper-
iments. *p < 0.05; **p < 0.01; ***p < 0.001; and
****p < 0.0001. All results are mean ± SEM.
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HSKO mice subjected to fasting and refeeding appropriately
downregulated gluconeogenic gene expression and nuclear
FoxO1 and upregulated Gck, similar to control mice, resulting
in no overt systemic abnormality in glucose regulation. In agree-
ment with our results, other studies have shown that hepatic in-
sulin signaling is dispensable for normal postprandial response
of gluconeogenic genes but required for inducing lipogenesis
through SREBP1c activation (Titchenell et al., 2015, 2016).
Although ABCA1 is critical for generating plasma HDL (Tim-
mins et al., 2005), it is also involved in endocytosis (Zha et al.,
2001), exocytosis (Kruit et al., 2011), intracellular vesicular
trafficking (Robenek and Schmitz, 1991; Schmitz et al., 1985;
Zha et al., 2003), and reducing membrane lipid rafts (Landry
et al., 2006; Zarubica et al., 2009; Zhu et al., 2008, 2010).
More recently, ABCA1 was implicated in retrograde transport
of FC from PM to ER (Yamauchi et al., 2015) to regulate ER
cholesterol content, a key step in controlling sterol biosynthesis
(Radhakrishnan et al., 2008), and autonomous regulation of
cellular membrane composition in response to cell crowding
Figure 7. Summary of Experimental Results
(A) Compared to chow-fed control (fl/fl) mice, he-
patic insulin signaling is reduced in chow-fed
HSKO mice due to reduced PM FC content (a)
from decreased trafficking of lysosomal FC to the
PM (b) and cholesterol biosynthesis (c). Blunted
insulin signaling leads to decreased activation
of the Akt-mTORC pathway (d) and decreased
expression and processing of SREBP1c (e), re-
sulting in reduced de novo lipogenesis (f). Regu-
lation of gluconeogenesis is unchanged in HSKO
versus fl/fl liver (g), but FA oxidation is increased
(h), perhaps due to the activation of glucagon
signaling (i). WTD-fed HSKO mice, compared to
control mice, have a similar phenotype with
decreased PM FC (a), decreased insulin signaling
(d), and reduced lipogenesis (f), resulting in
diminished hepatosteatosis. However, unlike in
chow-fed mice, the liver in WTD-fed HSKOmouse
had decreased FA uptake (j; dashed arrow) and
similar FA oxidation (k), compared to that in
WTD-fed control mice. LDLR, LDL receptor; GR,
glucagon receptor; AC, adenylate cyclase; IR, in-
sulin receptor; IRS, insulin receptor substrate.
(B) Proposed sequence leading to unique selec-
tive insulin resistance in HSKO mouse liver.
Downward arrows indicate decreased signal
pathway/molecule activation relative to fl/fl (con-
trol) mice; horizontal arrows denote no change.
The HSKO mouse liver shows a defect in the
Akt2 and mTORC1 response to insulin, with a
concomitant reduction in de novo lipogenesis.
FoxO1 and gluconeogenesis remain suppressed
by insulin.
(Frechin et al., 2015). In the latter study,
cultured cells with low crowding re-
sponded by downregulating ABCA1, re-
sulting in higher cellular cholesterol
content, more lipid droplets, and more
saturated cell membrane PL species.
A more rigid membrane structure results that affects membrane
receptor signaling, such as Akt phosphorylation, which critically
depends on membrane lipid raft domains for optimal activation
(Lasserre et al., 2008). Frechin et al. (2015) postulate that the
PM may act as a capacitor that converts signals to the correct
timescale and is tuned by enzymes that alter membrane lipid
composition and order. Our results with hepatocytes, and those
of Frechin et al. using non-hepatic cells, demonstrate a general-
izable and key role for ABCA1 in determining PM composition
and order, which modulates cellular signaling (i.e., insulin and
glucagon).
Using mouse embryonic fibroblasts from whole-body Abca1
knockout mice, endocytic retrograde FC movement from the
PM to the ER was impaired compared to that of WT mouse em-
bryonic fibroblasts, which increased activation of the SREBP2
pathway and cholesterol biosynthesis (Yamauchi et al., 2015).
Furthermore, these authors documented increased PM FC and
lipid raft content (i.e., flotillin-1 and caveolin-1), the opposite of
our findings in HSKO hepatocytes. We propose that ABCA1 is
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more dominant in antegrade FC transport than in retrograde
transport in hepatocytes, which are programmed to be secretory
cells. Defective vesicular trafficking and antegrade movement of
lipid occur in cells lacking ABCA1 (Robenek and Schmitz, 1991;
Schmitz et al., 1985; Zha et al., 2003). Despite increased cell-
associated [3H]-FC in HSKO hepatocytes, movement of lyso-
somal [3H]-FC cholesterol, liberated by the hydrolysis of LDL
[3H]-CE, to the PM, is impaired in ABCA1-deficient hepatocytes.
With reduced intracellular FC trafficking to the PM, ER FC may
increase, leading to the downregulation of FC and TG synthesis,
by decreasing SREBP1c processing and nuclear SREBP1c con-
tent (Nohturfft et al., 2000; Wang et al., 1994), as supported by
our results (Figure 2H). Thus, the role of ABCA1 in antegrade
and retrograde FC transport may be cell specific and dictated
by the overall need to take up or secrete lipid.
Mice completely lacking hepatocyte insulin receptors
(i.e., LIRKO) are hyperinsulinemic, with mildly elevated blood
glucose, but plasma TG concentrations are lower than in con-
trols (Biddinger et al., 2008). The pure insulin resistance in LIRKO
mice results in decreased de novo lipogenesis due to decreased
SREBP1c activation (Haas et al., 2012), unlike the selective insu-
lin resistance observed in mouse models of obesity/type 2 dia-
betes (i.e., ob/ob) or mice fed a WTD, both of which have
increased de novo lipogenesis, hepatosteatosis, and hypertri-
glyceridemia (Brown and Goldstein, 2008). Chow-fed HSKO
mice have some phenotypic features of LIRKO mice (Biddinger
et al., 2008; Haas et al., 2012), including elevated plasma
glucose concentrations (Figure S1J) and lower fasting plasma
TG concentrations (Chung et al., 2010). When challenged with
a HFD, both LIRKO (Haas et al., 2012) and HSKOmice (Figure 3)
had decreased body weight gain and were relatively protected
from hepatosteatosis, compared to control mice. However, un-
like LIRKO mice, HSKO mice were not hyperinsulinemic (Fig-
ure S1K), likely due to normal plasma insulin clearance by
hepatocyte insulin receptors and normal pancreatic insulin
secretion without significantly elevated plasma glucose levels.
Insulin signaling strongly activates lipogenesis by increasing
SREBP1c mRNA abundance and protein processing (Jeon and
Osborne, 2012). Chow-fed LIRKO andHSKOmice have reduced
SREBP1c expression and processing, compared to their
respective controls, when refed a high-carbohydrate chow diet
after a prolonged fast. These similarities suggest that HSKO
mice exhibit a phenotype more similar to pure insulin resistance
than selective insulin resistance (Brown and Goldstein, 2008). If
defective lysosomal FC trafficking to the PM reroutes FC traf-
ficking to the ER, as suggested by our RNA-seq and in vitro
cholesterol biogenesis data, then SREBP1c processing may
be further attenuated by ER INSIG-mediated retention of the
SCAP-SREBP1c complex (Engelking et al., 2004; Yabe et al.,
2003).
EXPERIMENTAL PROCEDURES
Mice
HSKOmice were generated by crossing fl/fl mice (Timmins et al., 2005) (back-
crossed into the >99% C57BL/6 background) with albumin Cre recombinase
transgenic mice (Jackson Laboratory). Age-matched (8–24 weeks of age)
male mice on chow (LabDiet 5P00 Prolab RMH 3000) or a WTD were used.
Eight-week-old chow-fed male mice were switched to WTD (42% fat calories,
0.2% cholesterol; Harlan Laboratories TD88137) for 16–24 weeks to induce
obesity, insulin resistance, and hepatic steatosis. All mice were maintained
in a specific pathogen-free environment on a 12-hr:12-hr light:dark cycle
(dark from 6 p.m. to 6 a.m.) and allowed free access to food and water. All
experiments were performed using a protocol approved by the Institutional
Animal Care and Use Committee at Wake Forest School of Medicine in facil-
ities approved by the American Association for Accreditation of Laboratory
Animal Care.
For the fasting/refeeding study, chow-fed mice (n = 3 per genotype) were
fasted for 24 hr (6 a.m. to 6 a.m.), and another group was fasted for 24 hr
(10 p.m. to 10 p.m.) followed by refeeding a high-carbohydrate chow (LabDiet
5P00 Prolab RMH 3000) for 8 hr (10 p.m. to 6 a.m.). All mice were terminated
between 6 a.m. and 7 a.m. Fresh liver (200 mg) was used to isolate nuclear
protein to examine SREBP1 expression (Bennett et al., 2008). The remainder
was immediately frozen in liquid nitrogen and stored at 80C until proteins
were isolated and RNA was extracted for western blotting and real-time
PCR, respectively.
Indirect Calorimetry
Indirect calorimetry was conducted as described previously (Thomas et al.,
2013). Food intake was independently verified over 14 days, using mice
housed in individual wire-bottom cages (Thomas et al., 2013).
Metabolic Measurements
Metabolic measurements were conducted as described previously (Chung
et al., 2010; Thomas et al., 2013), with slight modifications as detailed in the
Supplemental Experimental Procedures.
In Vivo TG Secretion Rate
In vivo TG secretion was measured by a detergent lipolysis block procedure
with radiolabeled oleic acid (Bi et al., 2013; Chung et al., 2010).
In Vivo Insulin Signaling Analysis
Liver, adipose tissue, and muscle insulin signaling were determined as previ-
ously described (Chung et al., 2010) with slight modifications; see Supple-
mental Experimental Procedures.
RNA-Seq and Real-Time PCR
RNA-seq and real-time PCR were performed as described in the Supple-
mental Experimental Procedures.
Western Blotting
Western blots were performed after protein fractionation using SDS-PAGE
(Chung et al., 2010). Antibodies used for western blots are listed in the Supple-
mental Experimental Procedures.
In Vitro Metabolic Analyses
Primary hepatocytes were isolated as described in the Supplemental Experi-
mental Procedures (Kreamer et al., 1986). Hepatic insulin signaling (Zhu
et al., 2010), glucagon signaling (Miller et al., 2013), lipogenesis (Thomas
et al., 2013), FA uptake (Li et al., 2013), and FA oxidation (Huynh et al., 2014)
were analyzed using methods described in the Supplemental Experimental
Procedures.
Lipid Analysis of PM Fraction Isolated from Primary Hepatocytes
Primary hepatocyte PM isolation was performed as previously described (Das
et al., 2013, 2014); see the Supplemental Experimental Procedures.
Intracellular Cholesterol Trafficking
Trafficking of lysosomal FC to the PM was measured as described in the Sup-
plemental Experimental Procedures (Sugii et al., 2003).
Lipidomic Analyses
Liver lipids were extracted from chow-fed mice (Folch et al., 1957) for mass
spectrometry quantification of lyso-PL (Bollinger et al., 2010) and PL head
group and fatty acyl species (Sorci-Thomas et al., 2012); see the Supplemental
Experimental Procedures.
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Immunofluorescence
Immunofluorescent staining was performed as described in the Supplemental
Experimental Procedures (Tamura and Yui, 2014).
Statistics
Results are presented as mean ± SEM. Data were analyzed using an unpaired
two-tailed Student’s t test, one-way ANOVAwith Tukey’s multiple comparison
test, or two-way ANOVA with Bonferroni’s multiple comparison test. When
unequal variance among groups was present, data were log-transformed
before performing ANOVA. All analyses were performed using GraphPad
Prism 7 software. Significant differences are denoted as follows: *p < 0.05,
**p < 0.01, ***p < 0.001, and ****p < 0.0001; for multiple comparisons, different
lowercase letters denote significant differences (p < 0.05; Figure 2).
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